Breakfast available at 8:00 AM
Chairs: Dennis Keefe, PhD and Alison Kretser, MS, RDN
Welcome & Introduction, Alison Krestser, MS, RDN, ILSI North America, Washington, DC
The Caffeine Landscape: Framing the Need for the Systematic Review, Dennis Keefe, PhD, US Food and Drug Administration, College Park, MD
Achieving the Gold Standard in the Systematic Review Process, Esther Myers, PhD, RDN, FAND, EF Myers Consulting, Trenton, IL
The Methodology and Challenges of the Caffeine Systematic Review: An Expert Perspecive, Daniele Wikoff, PhD, ToxStrategies
Discussion/Q&A
Break (10:10 - 10:25 AM)
General Results of the Systematic Review, Daniele Wikoff, PhD, ToxStrategies
Caffeine and Behavior, Harris Lieberman, PhD, US Army, Natick, MA
Caffeine and Behavior, Charles O'Brien, MD, PhD, University of Pennsylvania, Philadelphia, PA
Caffeine and Reproductive & Developmental Toxicology, Jennifer Peck, PhD, University of Oklahoma Health Sciences Center, Oklahoma City, OK
Caffeine & Cardiovascular Health, Gregory Brorby, PhD, ToxStrategies, Napa, CA
Caffeine, Bone & Calcium, Connie Weaver, PhD, Purdue University, West Lafayette, IN
Caffeine & Acute Toxicity & Pharmacokinetics, Milton Tenenbein, MD, University of Manitoba, Winnipeg, Manitoba CA
Panel Discussion with the Caffeine Systematic Review Project Team Members, Dennis Keefe, PhD